Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
Where M&A Value is Won or Lost
M&A can create significant opportunities for growth, but realising the expected value often depends on how effectively organisations manage the people side of a transaction. This report by LACE Partners explores how...
Jane Pateman, NED at Knights plc: What Changes from CPO to NED?
Moving from CPO to NED means shifting from execution to influence, challenge and oversight. In this episode, Bridgette Hall, Senior Editor at Criticaleye, speaks with Jane Pateman, NED at Knights plc and Critical...
Christina Chan, CFO, Asia Pacific at Marriott International on Leading as a Regional CFO
Christina Chan, CFO, Asia Pacific excluding China for Marriott International spoke to us about her career journey, leading as a regional CFO and finance as a driver for growth. Discussion points include: ...
Displaying 1 to 3 of 215
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
